Cargando…
The costs of treating vaginal and vulval cancer in England (2009–2015)
BACKGROUND: Human papillomavirus (HPV) infection is a pre-requisite for cervical cancer, which represents the third most common cancer among women worldwide. A causal relationship also exists between HPV and cancer in other areas of the female reproductive system including the vagina and vulva. Whil...
Autores principales: | Stephens, Stephanie, Chatterjee, Anuja, Coles, Victoria, Crawford, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137284/ https://www.ncbi.nlm.nih.gov/pubmed/32252711 http://dx.doi.org/10.1186/s12889-020-08545-4 |
Ejemplares similares
-
p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia
por: Rosenthal, A N, et al.
Publicado: (2000) -
Vulval elephantiasis
por: Palanisamy, Arun Prasath, et al.
Publicado: (2015) -
Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer
por: Soliman, A. A., et al.
Publicado: (2012) -
HPV vaccine in the treatment of usual type vulval and vaginal intraepithelial neoplasia: a systematic review
por: Bryan, Stacey, et al.
Publicado: (2019) -
Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma
por: Rosenthal, A N, et al.
Publicado: (2003)